Skip to main content
Premium Trial:

Request an Annual Quote

Rainer Lichtenberger, Stefan Kochanek

Premium
Cevec Pharmaceuticals this week announced the appointment of Rainer Lichtenberger as CEO, replacing Stefan Kochanek, a founder of the company, who had served as interim CEO.
 
Lichtenberg most recently was CEO of German biopharmaceutical development company Neuraxo Biotec. He also has held various positions, including vice president of strategic marketing and corporate vice president of business development at the Merckle/ratiopharm group and Merck.
 
Kochanek will continue to serve as a board member.
 
Cevec, based in Cologne, Germany, develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.